PhencynonateAlternative Names: PCNH; PHN 021
Latest Information Update: 16 Jul 2016
At a glance
- Originator PhytoHealth
- Class Antiemetics; Antiepileptic drugs; Aza compounds; Benzoic acids; Glycolates; Small molecules
- Mechanism of Action Cholinergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- Marketed Motion sickness
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Motion-sickness(Prevention) in Taiwan (PO, Tablet)